This study was aimed at clarifying the clinical reliability of AMS 700 CX prostheses in the treatment of Peyronie's disease and associated erectile dysfunction. Sixteen patients were treated: additional plaque surgery was performed in 8 cases (50%). Mean (±S.E.) operative time was 145 ± 8 min. Mean (±S.E.) postoperative hospitalization was 2.9 ± 0.8 days. Mean (±S.E.) time for returning to preoperative activity was 9.2 ± 2.1 days. In the early postoperative followup, 2 patients (12%) developed a wound infection which was treated conservatively. At the six-week followup, complete penile straightening was achieved in 11 patients (70%). After full activation of the implant, rigidity was considered good by all patients. However the penis was considered short by 6 patients (38%). Three diabetic patients (19%) complained of severe scrotal and penile pain during full activation of the implant. One of these patients (6%) required removal of the implant due to unbearable pain. One patient (6%) required repositioning of the reservoir from the Retzius space to inside the peritoneum due to 'spontaneous' erections occurring after implant deactivations. Thirteen patients were assessed at the long-term followup (mean 17 months): 12 of them (92%) reported regular sexual activity. Five of 8 partners (62%) were definitely satisfied with postoperative sexual activity. Three-piece inflatable implants allow good rigidity to be achieved in parties with Peyronie's disease. Patients must be fully informed about possible surgical morbidity and actual postoperative penile length.
|Number of pages||2|
|Journal||Acta Urologica Italica|
|Publication status||Published - 1995|
- penile prosthese
- Peyronie's disease
ASJC Scopus subject areas